Open for inclusion

A phase II, randomized, active-controlled, multi-center study comparing the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patients with cancer of unknown primary site...

Cancer type: Solide tumores

Phase: II

Principal Investigator: Suonpää Pia

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion

Link to